Romiplostim administration shows reduced megakaryocyte response-capacity and increased myelofibrosis in a mouse model of MYH9-RD. [electronic resource]
Producer: 20120619Description: 3333-41 p. digitalISSN:- 1528-0020
- Animals
- Bleeding Time
- Blood Platelets -- drug effects
- Bone Marrow -- metabolism
- Embolism -- chemically induced
- Factor IX -- metabolism
- Factor V -- metabolism
- Female
- Leukocyte Count
- Lung -- pathology
- Male
- Megakaryocytes -- drug effects
- Membrane Glycoproteins -- metabolism
- Mice
- Mice, Inbred C57BL
- Mice, Knockout
- Myosin Heavy Chains
- Nonmuscle Myosin Type IIA -- genetics
- P-Selectin -- metabolism
- Platelet Count
- Platelet Glycoprotein GPIIb-IIIa Complex -- metabolism
- Platelet Membrane Glycoproteins -- metabolism
- Primary Myelofibrosis -- metabolism
- Receptors, Fc -- administration & dosage
- Recombinant Fusion Proteins -- administration & dosage
- Reticulin -- metabolism
- Spleen -- cytology
- Thrombocytopenia -- genetics
- Thrombopoietin -- administration & dosage
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.